BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10565302)

  • 1. Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6).
    Obara N; Shinagawa A; Komatsu T; Abe T; Ninomiya H
    Cancer Genet Cytogenet; 1999 Nov; 115(1):62-4. PubMed ID: 10565302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
    Olopade OI; Thangavelu M; Larson RA; Mick R; Kowal-Vern A; Schumacher HR; Le Beau MM; Vardiman JW; Rowley JD
    Blood; 1992 Dec; 80(11):2873-82. PubMed ID: 1450412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of secondary leukemia associated with (1;7)(q10;p10) in a patient with Crow-Fukase syndrome.
    Satoh K; Miura I; Chubachi A; Utsumi S; Imai H; Miura AB
    Intern Med; 1996 Aug; 35(8):660-2. PubMed ID: 8894744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
    Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
    Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unbalanced 1;7 translocation in myelodysplastic syndrome following treatment of acute myeloblastic leukemia with an 8;21 translocation.
    Hamamoto K; Hashimoto-Ninomiya A; Kishimoto Y; Kimura T; Fujitake H; Yasunaga K; Horiike S
    Cancer Genet Cytogenet; 1994 May; 74(1):35-9. PubMed ID: 8194045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
    Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
    Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
    Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
    Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
    Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
    Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation (3;5)(q21;q34) in erythroleukemia: a molecular and in situ hybridization study.
    Kwong YL
    Cancer Genet Cytogenet; 1998 May; 103(1):15-9. PubMed ID: 9595039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
    Hsiao HH; Sashida G; Ito Y; Kodama A; Fukutake K; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo appearance of t(7;13)(q10;q33) in the leukemic phase of myelodysplastic syndrome: a case report.
    Iguchi T; Sashida G; Kawakubo K; Tauchi T; Kodama A; Fukutake K; Ohyashiki K
    Jpn J Clin Oncol; 2002 Jan; 32(1):35-6. PubMed ID: 11932362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivative (5;19)(p10;q10): a rare but recurrent whole-arm translocation in acute myeloid leukemia.
    Manabe M; Takakuwa T; Nakano H; Harada N; Okamoto S; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Matsuda M; Mugitani A
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e122-6. PubMed ID: 23279927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
    Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute erythroid leukemia (M6): outcome of bone marrow transplantation.
    Killick S; Matutes E; Powles RL; Min T; Treleaven JG; Rege KP; Atra A; Catovsky D
    Leuk Lymphoma; 1999 Sep; 35(1-2):99-107. PubMed ID: 10512167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
    Slovak ML; O'Donnell M; Smith DD; Gaal K
    Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.